Taking people in CanadaNo phase
Genome Analysis Across Populations in Inflammatory Bowel Disease
Key facts
- Where
- Toronto, CanadaSee the site
Where in Canada
- Sinai Health SystemToronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mount Sinai Hospital, Canada
- Trial code
- NCT06042387
- Record updated
- 9 October 2026
- Original description
Objective:Read full original descriptionShow less
Objective:
To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.
Inclusion: Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined); Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U)); Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss; Any age.
Exclusion: Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria.